MCC
CRL icon

Malaga Cove Capital’s Charles River Laboratories CRL Stock Holding History

Malaga Cove Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,022
Closed -$304K – 176
2025
Q1 		$304K Buy
2,022
+185
+10% +$31K 0.13% 151
2024
Q4 		$339K Sell
1,837
-64
-3% -$12.3K 0.13% 152
2024
Q3 		$374K Sell
1,901
-1,955
-51% -$406K 0.15% 144
2024
Q2 		$797K Buy
3,856
+591
+18% +$134K 0.32% 81
2024
Q1 		$885K Sell
3,265
-102
-3% -$24.4K 0.36% 75
2023
Q4 		$796K Buy
3,367
+615
+22% +$121K 0.34% 85
2023
Q3 		$539K Sell
2,752
-30
-1% -$6.16K 0.25% 106
2023
Q2 		$585K Hold
2,782
– – 0.27% 100
2023
Q1 		$561K Buy
2,782
+667
+32% +$151K 0.28% 101
2022
Q4 		$461K Buy
2,115
+385
+22% +$84.1K 0.25% 104
2022
Q3 		$340K Buy
+1,730
New +$373K 0.19% 118

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Malaga Cove Capital's CRL Position: Q2 2025 in Review

Malaga Cove Capital sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 2,022 shares — an estimated $304K sold.

Malaga Cove Capital first reported a position in CRL in Q3 2022 and held it in 11 quarters. The position peaked at $885K in Q1 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Malaga Cove Capital reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Malaga Cove Capital sold 2,022 Charles River Laboratories shares in Q2 2025, an estimated $304K.
  • Malaga Cove Capital first reported a position in Charles River Laboratories in Q3 2022 and held it in 11 quarters.
  • Malaga Cove Capital's Charles River Laboratories position peaked at $885K in Q1 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Malaga Cove Capital's 13F filing for Q2 2025, filed 6 Aug 2025.